Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 29 clinical trials
None
Treatment Outcome and Prognostic Factors for Rheumatoid Arthritis (RA) Patients With Interstitial Lung Disease (ILD)

modifying antirheumatic drug (DMARD) and biologic DMARD treatments in rheumatoid arthritis patients with ILD in the real-world setting

biologic disease-modifying antirheumatic drug
chest ct
DMARD
antirheumatics
interstitial lung disease
  • 28 views
  • 25 Jan, 2021
  • 1 location
None
Observational Registry of Patients With Rheumatoid Arthritis /Spondyloarthritis Using Biological or Targeted Synthetic DMARDs

synthetic disease-modifying antirheumatic drug (DMARD) and the doses and side effects of these drugs. The aim of this registry is to evaluate the real-life data of participants receiving these medications

anti rheumatic drugs
psoriatic arthritis
DMARD
antirheumatics
spondyloarthropathy
  • 4 views
  • 23 Jan, 2021
  • 14 locations
None
Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases

-sectional blood sample (i.e. whole blood, serum, EDTA-plasma and -buffy coat, and blood in PAXgene RNA tubes) and/or are enrolled for longitudinal follow-up upon start of new DMARD (blood sampling after 0

rheumatic diseases
biological materials
DMARD
spondyloarthropathy
arthritis
  • 286 views
  • 24 Jan, 2021
  • 12 locations
None
Pharmacovigilance in Juvenile Idiopathic Arthritis Patients Treated With Biologic Agents and/or Methotrexate

of NSAIDs and intra-articular steroid injections. In those patients not responding to NSAIDs, methotrexate (MTX) has become the disease modifying anti-rheumatic drug (DMARD) of first choice worldwide

rheumatism
DMARD
NSAID
arthritis
methotrexate
  • 6 views
  • 22 Jan, 2021
  • 1 location
None
Prognostic Evaluation of Inflammatory Polyarthritis of Recent Onset

Inflammatory joint diseases are major causes of invalidity and morbidity. Rheumatoid arthritis (RA), the most frequent of chronic arthritides, affects close to 1% of the Canadian population. Direct and indirect costs of RA represent close to 1% of the gross national product. Recent evidence suggest that initiation of early (e.g., …

rheumatoid arthritis
arthropathy
polyarthritis
  • 8 views
  • 12 Mar, 2021
  • 1 location
None
PANLAR's Latin American Registry of Rheumatic Patients Treated With Jak Inhibitors

This prospective, non-interventional, research registry is designed to study the comparative safety and comparative effectiveness of approved Jak Inhibitors treatment for RA-PsA-SpA in a cohort of patients and theirs controls cared for by rheumatologists across Latin Amrica (LA).

  • 0 views
  • 05 Apr, 2021
  • 2 locations
None
Effects of Tofacitinib on Body Composition Bone Mineral Density and Bone Marrow Adiposity in Patients With Rheumatoid Arthritis: the TOFAT Project

the case with tofacitinib (targeted synthetic DMARD or tsDMARD) while preliminary data let us think that this treatment may influence body composition and bone mineral density. This study is

tofacitinib
DMARD
antirheumatics
methotrexate
rheumatic diseases
  • 0 views
  • 24 Jan, 2021
None
Study of Tapering and Discontinuing Biological DMARDs in Rheumatoid Arthritis Patients

This study aims to analyses time to disease relapse of RA patients if TNF- inhibitors are being tapered, the predictive factors that are associated with successful taper of TNFinhibitors. Also, investigate the effects associated with dose tapering of TNF- inhibitors.

DMARD
tumor necrosis factor
tumor necrosis factor alpha
  • 0 views
  • 25 Jan, 2021
  • 1 location
None
CPMC Early Undifferentiated Arthritis Registry

The CPMC early arthritis registry will recruit participants from a population of new patients undergoing evaluation at the office of participating physicians. Patients enrolled in the registry will undergo longitudinal observation and sampling. The investigators will collect questionnaire data and create a biological sample repository. The information obtained will be …

DMARD
rheumatic diseases
  • 143 views
  • 15 May, 2021
  • 1 location